Nav Bajaj

Cardiologist. Personal opinions and thoughts. RTs ≠ Endorsement.

[Nav Bajaj @bajaj_nav]

Link between chronic kidney disease and heart failure is identified in patients https://t.co/FMLSxrIblo

[Gregg Fonarow MD @gcfmd]

HFrEF
Intolerant or contraindication to beta-blockers
NSR

Ivabradine ➡️

29% ⬇️ CV☠️/HF🏨 (9.9% ARR, NNT=10)

38% ⬇️ HF🏨 (9.8% ARR)

20% ⬇️ CV☠️ (trend, 5.5% ARR)

Cost $22/month

Worth it?

[Gregg Fonarow MD @gcfmd]

HFrEF

Q-GDMT (ARNI+BB+MRA+SGLT2i)

🛟 Extend median overall survival by 7-11 YEARS

Self-pay cash price all 4 💊

$121 per month

🎰 Incredible value

✅ Available now

What is your diagnosis to Q-GDMT time? ⏱️

[Dutch Rojas @DutchRojas]

FINAL THOUGHT:

If you’re tired of expensive, inaccessible healthcare disguised as “patient protection,” share this.

Tag someone who thinks healthcare policy makes sense.

Follow, Subscribe, and join @DutchRojas.

The truth is often uncomfortable,
but it’s never boring.

[Gregg Fonarow MD @gcfmd]

HFrEF

ARNI+BB+MRA+SGLT2i

Extend median survival by 7-11 YEARS

Self-pay cash price for all 4 💊

$121 per month

Available today

[Nav Bajaj @bajaj_nav]

@AnkurGuptaMD @ziadalinyc @AlokSharma081 @cathjockey72 @RizikMd @Babar_Basir @KAlaswadMD @SCAI Great work

[Ankur Gupta MD PhD @AnkurGuptaMD]

Must read short thread

[Nav Bajaj @bajaj_nav]

@nishantshahmd @BrownMedicine @odissi @athenapoppas @JDawnAbbott1 @GChoudharyMD Congrats!

[Mark Cuban @mcuban]

I can't imagine the stress or having to make life or death decisions for patients. The pain of dealing with death and tragedy. Intellectually we all know that Twitter isn't really representative of anything but Twitter. But the abuse on this platform towards MDs is wrong

[Mark Cuban @mcuban]

Every MD knows they are not going to be right every time, it's impossible to be, but they will do their best . Every day. Are some better than others. Yes. Are there politics?More than most professions. But to dismiss MDs as being "bought" is wrong.

[Mark Cuban @mcuban]

I want to share what I think about MDs. I love each and everyone that busted their ass, borrowed too much money, sacrificed more than we can ever quantify, in hopes of helping their patients. Medicine is an imprecise science. The uncertainties far outnumber the absolutes.

[Nav Bajaj @bajaj_nav]

Sudden Cardiac Death Risk in HFpEF: A New Marker? https://t.co/5Yuqmn87dx @UABCardiology @krtkgpt @uabmedicine

[Haitham Ahmed, MD, MPH @haithamahmedmd]

When hospitals recruit “Chief Wellness Officers” it makes me question their leadership.

Because they could’ve recruited medical scribes, nurses, records curators, social workers, discharge coordinators instead - and that would’ve improved “wellness” more than any officer can.

[Nav Bajaj @bajaj_nav]

@WunanZhou Looks great in print @UABCardiology

[Nav Bajaj @bajaj_nav]

Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure https://t.co/ucSn6peMR6

[Nav Bajaj @bajaj_nav]

Alabama students throwing 'COVID parties' to see who gets infected: Officials - ABC News via @ABC - https://t.co/fW8kgSLwaV

[Nav Bajaj @bajaj_nav]

⁦@krtkgpt⁩ ⁦@AnkurGuptaMD⁩ ⁦@WunanZhou⁩ ⁦@amitojdr⁩

[Muthu Vaduganathan @mvaduganathan]

Is metformin an effective "mitotrope" in HF? (h/t @mpsotka)

Commentary w @bajaj_nav on a small but intriguing mechanistic RCT pub in @ESC_Journals #EJHF of metformin on myocardial efficiency in HF+prediabetes. Key role of PET as an investigative platform

https://t.co/seicOAkJBq

[Nav Bajaj @bajaj_nav]

How can PET provide mechanistic insights into Heart Failure: Read our editorial with Dr @mvaduganathan, Using antimatter to uncover what matters: metformin effects on myocardial efficiency in heart failure https://t.co/TwDSJv7gGK @UABCardiology @uabmedicine